Shaista Hayat

Intrinsic resistance to the MEK1/2 inhibitor AZD6244 (ARRY‐142886) is associated with weak ERK1/2 signalling and/or strong PI3K signalling in colorectal cancer cell lines

Kathryn Balmanno, Simon Chell, Annette S. Gillings et al. · International Journal of Cancer · 2009 · 143 citations

Peripheral innate immune and bacterial signals relate to clinical heterogeneity in Parkinson’s disease

Ruwani Wijeyekoon, Deborah Kronenberg‐Versteeg, Kirsten M. Scott et al. · Brain Behavior and Immunity · 2020 · 107 citations · Full text

Abnormalities of age-related T cell senescence in Parkinson’s disease

Caroline H. Williams‐Gray, Ruwani Wijeyekoon, Kirsten M. Scott et al. · Journal of Neuroinflammation · 2018 · 103 citations · Full text

DUSP6/MKP-3 inactivates ERK1/2 but fails to bind and inactivate ERK5

Rebecca S. Arkell, Robin J. Dickinson, Matthew Squires et al. · Cellular Signalling · 2007 · 90 citations

Dusp6/mkp-3 Inactivates Erk1/2, Systems Biology

Selective inhibition of MEK1/2 reveals a differential requirement for ERK1/2 signalling in the regulation of HIF-1 in response to hypoxia and IGF-1

Kym Sutton, Shaista Hayat, N-M Chau et al. · Oncogene · 2007 · 64 citations

Differential Requirement, Selective Inhibition, Reductive Stress +10